Smoking does not reduce the functional activity of serum alpha-1-proteinase inhibitor. An epidemiologic study of 719 healthy men.
The present study was aimed at testing the hypothesis that smoking, the major risk factor for the development of pulmonary emphysema, impairs the functional activity of alpha 1-proteinase inhibitor (alpha 1-antitrypsin). We used a population of 719 apparently healthy subjects. The serum concentrations of immunoreactive and functionally active alpha 1-proteinase inhibitor were measured by radial immunodiffusion and inhibition of porcine pancreatic elastase, respectively. Both the immunoreactive and functionally active levels of serum alpha 1-proteinase inhibitor were found to increase with tobacco consumption, but the ratio between the 2 concentrations was independent of smoking. Smoking does not, therefore, impair the functional activity of alpha1-proteinase inhibitor.
D000328:Adult; D002248:Carbon Monoxide / Q000097:blood; D004812:Epidemiologic Methods; D006801:Humans; D005779:Immunodiffusion; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D012907:Smoking; D000515:alpha 1-Antitrypsin / Q000276:immunology / Q000502:physiology*
D000515:alpha 1-Antitrypsin; D002248:Carbon Monoxide